The Center Faculty come from all four UCSF Schools and conduct research and teaching in every aspect of tobacco control, from efforts by the tobacco industry to manipulate international politics to the molecular biology of nicotine addiction.

Danielle Ramo-Larios, PhD

Associate Professor

Using digital media to change health risk behaviors including tobacco, alcohol, and other drug involvement.

Rita Redberg, MD, MS


Effects of secondhand smoke and other work related conditions (radiation) on flight attendants, technology assessment and preventive cardiology.

Sujatha Sankaran, MD

Associate Professor

Smoking cessation, particularly in the hospital environment, tobacco use in low and middle income countries.

Jason Satterfield, PhD, MA

Dir of Behavioral Medicine

Implementation of evidence-based behavioral interventions in primary care including screening, brief interventions, and behaviorally-based treatments for tobacco and substance use disorders.

Suzaynn Schick, PhD

Associate Professor

Effects of exposure to secondhand cigarette smoke on the upper and lower respiratory tract in human subjects and the chemical and physical changes that occur in aging secondhand smoke.

Laura Schmidt, PhD, MSW, MPH

Professor in Residence
Institute for Health Policy Studies

Dr. Schmidt's central goal is to bridge the worlds of biomedical research, clinical practice and population health in ways that help us better understand some of the most pressing issues in health and health care today: the widening of health disparities and the societal of regulation risk factors in chronic disease. Substantive areas of her research include addiction, poverty, obesity-related metabolic disease—all burdens that are profoundly influenced by the organization of care and the social environment. A hallmark of her research is blended methodologies: she incorporates historical-archival, ethnographic and quantitative methods into most of her studies as a way to cross-validate findings and better interpret their meaning. Since its inception, her research program has been stably funded through awards from the National Institutes of Health (NIH) and US Substance Abuse and Mental Health Services Administration, in combination with funding from private foundations, including the Laura and John Arnold Foundation, Robert Wood Johnson Foundation (RWJF), Commonwealth Fund, Atlantic Philanthropies and Crossfit Foundation.

Steve Schroeder, MD


Determinants of medical expenditures, efficacy of medical cost containment, quality of care, and tobacco control with an emphasis on smoking cessation.

Mark Schumacher, MD, PhD


My goal is to leverage a better understanding of peripheral pain transduction to inspire more effective and non-addictive treatments for pain. In collaboration with the Hellman laboratory, we are investigating the role of TRPV1 and CB1 in sensory neurons as anti-inflammatory and analgesic targets for the minor cannabinoids.

Joel Simon, MD, MPH

Professor Emeritus

Hospital-based and out-patient clinical trials of smoking cessation.

Elizabeth Smith, PhD

Social Behavioral Sciences

"Legitimate" tobacco industry activities, and tobacco industry relationships with other groups.